In a recent note to clients, Byron Capital's Healthcare and Biotech Analyst Douglas Loe reiterated his Speculative Buy target on Protox Therapeutics … [Read more...] about Byron Capital’s Douglas Loe: the Market is Undervaluing Protox Therapeutics
prx
10 Canadian Life Sciences Stocks that could Change the World
It's been nearly a century since Canada's greatest achievement in biotech took place; the discovery of insulin by Frederick Banting and his assistant … [Read more...] about 10 Canadian Life Sciences Stocks that could Change the World
